Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Research literacy

Animal Studies vs Human Studies in the Peptide Literature

Most grey-market peptide claims lean on animal models. Independent 2026 sports-medicine reviews of those compounds describe human trials as scarce and weakly controlled.

Therapept EditorialUpdated 12 September 20267 min readReviewed by Therapept Editorial

An animal finding is evidence about that model. Translation is a separate empirical question. Therapept’s BPC-157 file, for example, is dominated by rodent work and reviews that say human orthopaedic inference is not supported.

Approved drugs in the same library (semaglutide, tirzepatide, tesamorelin, bremelanotide) have human interventional records. The UI is meant to make that difference visible without a score.

Sources

  1. Mayfield et al., Am J Sports Med (2026)
  2. Tewari et al., Am J Sports Med (2026)

This article is informational. It is not medical, legal or financial advice. Editorial policy · Report a correction